Click here to go to the previous page
Flatbush Diabetes: Unique Pathophysiologic Features of Type 2 Diabetes in Patients of African or Southeastern Asian Descent
Program Code:
S30-1
Date:
Sunday, June 5, 2011
Time:
9:30 AM to 10:00 AM
EST
SPEAKER
:
Mary Ann Banerji, MD, SUNY HEALTH SCI CTR
Disclosures: MAB: Consultant, Bristol-Myers Squibb, Novartis Pharmaceuticals; Research Grant Recipient: Abbott Laboratories, Amylin Pharmaceuticals, Roche Pharmaceuticals, Takeda, Merck & Co.; Speaker Bureau, Merck & Co.